This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
Hepatitis C virus core antigen monoclonal antibody, clone 6A1 (FITC)
catalog :
MAB5512
quantity :
100 ug
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
6A1
application :
immunocytochemistry, immunoprecipitation, enzyme immunoassay, immunohistochemistry - frozen section
citations: 6
Reference |
---|
Huynh D, Nguyen D, Pulst Korenberg J, Brice A, Pulst S. Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death. Exp Neurol. 2007;203:531-41 pubmed
|
product information
catalog id :
MAB5512
product name :
Hepatitis C virus core antigen monoclonal antibody, clone 6A1 (FITC)
product description :
Mouse monoclonal antibody raised against recombinant hepatitis C virus core antigen.
clone name :
6A1
isotype :
IgG2a
immunogen :
Recombinant protein corresponding to hepatitis C virus (HCV) core antigen.
form :
Liquid
recommend dilutions :
The optimal working dilution should be determined by the end user
storage buffer :
In PBS, pH 7.2 (0.01% sodium azide)
storage instruction :
Store at 4 C. For long term storage store at -80 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
conjugate tag :
FITC
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Hepatitis C virus (HCV)
specificity :
HCV core antigen. Recognizes 1-80 amino acid residues of HCV core antigen.
species reactivity cross reactivity :
Viruses
application key :
IP,ELISA,IHC-Fr,IF,EIA
size :
100 ug
autodate :
2010-01-04
updatetime :
2015-07-29 13:45:26
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments